Evidence map›Paper›PMID 27287408›Full record

ArticleEuropean journal of pediatrics2016

Paediatric chronic suppurative lung disease: clinical characteristics and outcomes.

Vikas Goyal, Keith Grimwood, Julie M Marchant, I Brent Masters, Anne B Chang

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Mucolytics for children with chronic suppurative lung disease.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Antibiotics for prolonged wet cough in children.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Is bronchiectasis really a disease?European respiratory review : an official journal of the European Respiratory Society · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Vikas GoyalCentre for Children's Health Research, University of Queensland, Raymond Terrace, South Brisbane, Queensland, 4101, Australia. drvikasgoyal@gmail.com.ORCID http://orcid.org/0000-0001-7533-2315
Keith GrimwoodCentre for Children's Health Research, University of Queensland, Raymond Terrace, South Brisbane, Queensland, 4101, Australia.
Julie M MarchantCentre for Children's Health Research, University of Queensland, Raymond Terrace, South Brisbane, Queensland, 4101, Australia.
I Brent MastersDepartment of Respiratory and Sleep Medicine, Lady Cilento Children's Hospital, Brisbane, Queensland, 4101, Australia.
Anne B ChangCentre for Children's Health Research, University of Queensland, Raymond Terrace, South Brisbane, Queensland, 4101, Australia.
Children's Medical Research Institute · AUChildren's Health Queensland Hospital and Health Service · AUGriffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledWe describe the clinical, bronchoscopic, bronchoalveolar lavage (BAL) and radiographic characteristics of children whose chronic wet cough did not resolve with oral antibiotics and which led to their hospitalisation for intravenous antibiotics and airway clearance therapy. Between 2010 and 2014, medical chart review identified 22 such children. Their median cough duration was 26 weeks (interquartile range (IQR) 13-52). All received oral antibiotics immediately before their hospitalisation (median 4 weeks; IQR 4-6.5). On chest examination, seven (31 %) children had auscultatory crackles. At bronchoscopy, 9 (41 %) had tracheomalacia, 18 (86 %) demonstrated airway neutrophilia (>15 %) and 12 (57 %) grew Haemophilus influenzae from their BAL fluid. They received intravenous antibiotics (mostly cefotaxime or ceftriaxone) and airway clearance therapy as inpatients (median 12.5 days (IQR 10.8-14). All were cough-free at follow-up.

conclusionThe children's BAL characteristics are similar to those with protracted bacterial bronchitis and bronchiectasis, but their poor clinical response to oral antibiotics and non-specific chest CT findings differentiated them from these other two disorders. The findings are consistent with chronic suppurative lung disease. Intravenous antibiotics and airway clearance therapy should therefore be considered in children whose wet cough persists despite 4 weeks of oral antibiotics and where other causes of chronic wet cough are absent. What is known on this topic? • Chronic wet cough not resolving with appropriate antibiotics increases the likelihood of bronchiectasis. • Children with chronic suppurative lung disease (CSLD) have clinical features of bronchiectasis, but lack the radiographic evidence for this diagnosis. WHAT THIS STUDY ADDS: • Children with CSLD have airway neutrophilia and predominantly Haemophilus influenzae in lower airway cultures, similar to children with protracted bacterial bronchitis and bronchiectasis. • Chronic wet cough in CSLD, unresponsive to oral antibiotics, resolves with intravenous antibiotics and airway clearance therapy.

Indexed as

Administration, IntravenousAdministration, OralAdolescentAnti-Bacterial AgentsBacterial InfectionsBronchiectasisBronchitisBronchoalveolar LavageBronchoscopyChildChild, PreschoolChronic DiseaseCoughFemaleHospitalizationHumansAnti-Bacterial AgentsAirway clearance therapyAntibioticsChildrenChronic suppurative lung disease

Identifiers

PMID27287408
OpenAlexW2416099465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.